¨àµ£ªñµø¤ñ¨ÒÃk¤É¡I ÂåÅñ¡G°ª«×ªñµø®£¾É­P¦hºØ²´²y¯fÅÜ

2023-09-25 1054

³£¥«¤Æ¡B¼Æ¦ì¤Æ¼vÅT¥[³t¨àµ£ªñµø«×¼Æ¼Wªø¡A¥xÆW¨àµ£ªñµøªº¤ñ¨Ò¦bªF¨È°ê®a¤¤¦W¦C«e­T¡C°ª«×ªñµø®£¾É­P¦­µo©Ê¥Õ¤º»Ù¡Bµøºô½¤­éÂ÷¡Bªñµø©Ê¶À´³³¡¯fÅÜ©M«C¥ú²´µ¥«Â¯Ù¡C

¥xÆWªñµø¤H¤f¶W¹L63%¡A¥B¨àµ£ªñµø¤ñ¨Ò¦bªF¨È¦a°Ï¦W¦C«e­T¡A°ª«×ªñµø®£¾É­P¦­µo©Ê¥Õ¤º»Ù¡Bµøºô½¤­éÂ÷¡Bªñµø©Ê¶À´³³¡¯fÅÜ©M«C¥ú²´µ¥«Â¯Ù¡C²´¬ìÂå°|°|ªø³¯¬áªå´£¿ô¡A¨àµ£ªñµø»Ý¤Î¦­ªvÀø¡A²´¬ì¶E©Ò°|ªø§d¬R·_¤]ªí¥Ü¡A¬°«Ä¤l¿ï¾Ü³Ì¾A¦XªºªvÀø¤è¦¡¡A¨Ò¦pªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãè¡A¦bªñ¦~¨Ó¦³¬ã¨sÃÒ¹ê¯à¦³®Ä±±¨î©Î´î½w¨àµ£µø¤O´c¤Æªºµ{«×¡C

³£¥«¤Æ¡B¼Æ¦ì¤Æ¼vÅT¡@¨àµ£ªñµø¤ñ¨Ò¦W¦C«e­T

¥xÆW³QºÙ¬°¡uªñµø¤§³£¡v¡A2018¦~ªºªñµø¤ñ²v¬°63.3%¡A¤ñ1986¦~ªº26.5%¼W¥[2.4­¿[i] ¡A¤×¨ä¥xÆW¤j¬ù24%ªºªñµø¤H¤f¬°°ª«×ªñµø[ii] ¡A§Y¨C5¤H¦³1¤H¦b¦¨¦~®É­±Á{²´·ú¯e¯fªº¬ÛÃö­·ÀI¡A¨Ò¦p¦­µo©Ê¥Õ¤º»Ù¡Bµøºô½¤­éÂ÷¡Bªñµø¶À´³³¡¯fÅÜ¡A¥H¤Î«C¥ú²´[iii] ¡A¦Ó¥Ñ°ª«×ªñµø©Ò¾É­Pªº¶À´³³¡¯fÅÜ¡A§ó¬O¥xÆW¤H¥¢©úªº¥D­n­ì¦][iv]¡C

¨ü¨ì³£¥«¤Æ¡B¼Æ¦ì¤Æ¼vÅT¡A¨àµ£ªñµø«×¼Æ¼Wªø¡A¥xÆW¨àµ£ªñµøªº¤ñ¨Ò¦bªF¨È°ê®a¤¤¦W¦C«e­T¡A¥B¦bCOVID-19ªº¬Ì«á®É¥N¡Aªñµø¤ñ¨Ò¤]¦³¤W¤É²{¶H¡C

³¯¬áªåªí¥Ü¡A¥Ñ©ó¬Ì±¡¶¡¯Ê¤Ö¤á¥~¬¡°Ê®É¶¡¡A¬O¨àµ£ªñµø«×¼Æ¥[²`ªº­ì¦]¤§¤@¡C¥t¥~ÀHµÛ¶V¨Ó¶V¦h¾Ç®Õ¡B¸É²ß¯Z¨Ï¥Î¥­ªO©M¼Æ¦ì¥ÕªOµ¥§@¬°±Ð§÷¡A¾Ç¥Í¨Ï¥Î¼Æ¦ì¤u¨ãªº®É¼Æ¦³¼W¥[ÁͶաA¦]¦¹¦b³£¥«¤Æ¤Î¾Ç·~À£¤O¤U¡A¥xÆW³£¥«¨àµ£§ó®e©ö¥B§Ö³t¥[²`ªñµø«×¼Æ¡A¨Ã¦b°ª¤¤²¦·~«á­±Á{°ª«×ªñµø­·ÀI¡C¦o©IÆ~¡G¡u¤Î¦­ªvÀø¡A¥i¦³®Ä±±¨î¤Î´î½wªñµø¶i®i¡C¡v

ªñµøÁB¥¿4¤jªvÀø¤è¦¡¡@©w´Á¦^¶E¬°±±¨îÃöÁä

¨àµ£ªñµøÁB¥¿ªº¤è¦¡¦h¤¸¡A§d¬R·_ªí¥Ü¡A¥Ø«e´²Àû¾¯²´ÃĤô¬O±`¨£ªº¨àµ£ªñµøªvÀø¡AµM¦Ó¨ä°Æ§@¥Î¥]§t¬È¥ú©Î¹ï¥ú±Ó·P¡A¥i¯à³y¦¨ÁB¥¿®É¤£¾AÀ³¡A¥B¦³¬ã¨s«ü¥X¡A´²Àû¾¯²´ÃĤôªºªvÀø®ÄªG¥i¯àÀHµÛªñµø¶i®i¦Ó­°§CªvÀø®ÄªG[v]¡C

•´²Àû¾¯²´ÃĤô
•°tÀ¹Ãè¤ù
•¨¤½¤¶ì«¬¤ù
•ªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãè


°£¤F´²Àû¾¯²´ÃĤô¡AÁB¥¿¤è¦¡ÁÙ¦³°tÀ¹Ãè¤ù¡B¨¤½¤¶ì«¬¤ù¥H¤Îªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãè¡C³¯¬áªå¸É¥R¡G¡uªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãèµ¥¸û·s¿oªºÁB¥¿ªvÀø¡A³q±`¹ï¬¡°Ê¶q¤jªº«Ä¤l§ó¥[«K§Q¡A¦b¤á¥~¬¡°Ê®É¡A¥i¥H¤£¨ü²´Ã誺­­¨î¡B¬¡°Ê¹Lµ{¤¤¸û¦w¥þ¡A¥B¤é©ß«¬ªº³n¦¡Áô§Î²´Ã褣¹³¨¤½¤¶ì«¬¤ù¶·¨C¤Ñ²M¼ä¡A¤]¥i­°§C¦]Ãè¤ù²M¼ä¤£¥þ¦Ó¾É­Pªº·P¬V­·ÀI¡C¡v

ªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãè¡@¥i´î½w«×¼Æ¼Wªø

¦b¤@¥÷ªø¹F7¦~ªº¬ã¨s¡A¬ã¨s¹ï¶H½d³ò²[»\8¦Ü17·³ªº¨àµ£¡Aµ²ªG«ü¥X¡A¦b¬ã¨sªº«e6¦~°tÀ¹ªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ã誺¨àµ£¡Aªñµø´c¤Æµ{«×¥­§¡­°§C¤F¬ù50%¡A¥B¦~¬ö¸û¤jªº¨àµ£°tÀ¹ªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãè¡A¤]¥i¥H­°§C¤@¥bªºªñµøµ{«×¡C³Ì·s¬ã¨sµ²ªG§ó«ü¥X¡A°tÀ¹ªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ã誺ªñµø±±¨î®ÄªG¡A¦b°tÀ¹ªº¶g´Áµ²§ô«á¤´«ùÄò¦s¦b[vi] ¡C

§d¬R·_ªí¥Ü¡G¡u¹L¥h2¦~¡A¦Û¤vªº«Ä¤l¤]¤@ª½°tÀ¹ªñµø±±¨î±M¥Î¤é©ßÁô§Î²´Ãè¡A¥L­Ìªºªñµøµ{«×©úÅã¹F¨ì´î½w¡A¥B°tÀ¹¤W¤ñ¨¤½¤¶ì«¬¤ù§ó³n¤]§óµÎ¾A¡A¦]¦¹§ó®e©ö¾AÀ³¡C¡v¥L¤]«Øij¡A«Ä¤l¬O§_¯à«ùÄò¶i¦æªvÀø¬°ÁB¥¿ÃöÁä¡A¦]¦¹®aªø»Ý¿ï¾Ü«Ä¤l³Ì¯à°÷¾AÀ³ªº¤è¦¡¨Ó¶i¦æªñµøÁB¥¿¡A¥B©w´Á¦^¶EÀˬdµø¤O¡A¤~¯àªø¤[¥B«ùÄò¦a±±¨îªñµø¡AÁקK´c¤Æ¡C

[i] Lu, P. C. S. (2020). Assessment of Five-Year Myopia Intervention Study in Taipei (MIT) Program for Delaying Myopia Progression in Taipei Primary Schools (Doctoral dissertation, The Johns Hopkins University). Available at:
https://jscholarship.library.jhu.edu/handle/1774.2/62593.

[ii] Hung, T. (2001). Epidemiologic study of the prevalence and severity of myopia among schoolchildren in Taiwan in 2000. J Formos Med Assoc, 100(10), 684-91.
http://www.fma.org.tw/jfma/PDF/2001-100/issue_10/Article_6.pdf.

[iii] Cheng, H. C., Chang, K., Shen, E., Luo, K. S., & Ying, Y. H. (2020). Risk factors and behaviours of schoolchildren with myopia in Taiwan. International Journal of Environmental Research and Public Health, 17(6), 1967.
https://pubmed.ncbi.nlm.nih.gov/32192125/.

[iv]Hsu, W. M., Cheng, C. Y., Liu, J. H., Tsai, S. Y., & Chou, P. (2004). Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology, 111(1), 62-69.
https://pubmed.ncbi.nlm.nih.gov/14711715/.

[v] Fu, A., Stapleton, F., Wei, L., Wang, W., Zhao, B., Watt, K., ... & Lyu, Y. (2020). Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. British Journal of Ophthalmology, 104(11), 1535-1541.
https://web.archive.org/web/20210116090601id_/https://bjo.bmj.com/content/bjophthalmol/104/11/1535.full.pdf.

[vi] Hammond D, Arumugam B, et al. (2021) Myopia Control Treatment Gains are Retained after Termination of Dual focus Contact Lens Wear with no Evidence of a Rebound Effect. Optometry and Vision Science, 98, E-abstract 215130.

¥»¤å¸g °·±dÂåÀøºô ±ÂÅv¥Zµn¡A­ì¤åµoªí©ó¦¹
¡i°·±dÂåÀøºô¡þ°OªÌ¾G©yªâ³ø¾É¡j2023/09/24

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');